| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 664581 | 61846 | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 100 ml | 10 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61846/61846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61846/61846_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | LABORATORIOS HARTMANN S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 0 | 2011-10-26 | View Edit Delete | ||||||||||||
| 664599 | 61846 | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 50 ml | 10 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61846/61846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61846/61846_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | LABORATORIOS HARTMANN S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 0 | 2011-10-26 | View Edit Delete | ||||||||||||
| 664347 | 56811 | RESPIBIEN ANTIALERGICO SOLUCION PARA PULVERIZACION NASAL | RESPIBIEN ANTIALERGICO SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 15 ml | 0,5 mg/ml + 0,5 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56811/56811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56811/56811_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 2010-03-15 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 664496 | 71816 | RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71816/71816_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71816/71816_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-01-14 | 1 | 1 | 1 | 2010-01-14 | 2010-01-14 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 664267 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 50 ml | 40 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2009-11-19 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 663728 | 71281 | AERO-RED 120 mg COMPRIMIDOS MASTICABLES | AERO-RED 120 mg COMPRIMIDOS MASTICABLES, 40 comprimidos | 120 mg | 6 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71281/71281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71281/71281_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42358 | URIACH AQUILEA OTC, S.L. | 2009-07-30 | 1 | 1 | 1 | 2009-07-30 | 2009-07-30 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 664462 | 71777 | RIVASTIGMINA COMBIX 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA COMBIX 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jerinda dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71777/71777_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71777/71777_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2012-10-16 | View Edit Delete | ||||||||||||
| 664101 | 99108003 | FERRIPROX 100 MG/ML SOLUCION ORAL | FERRIPROX 100 MG/ML SOLUCION ORAL , 1 frasco de 500 ml | 100 mg/ml | 6 | 500 | 26 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99108003/99108003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99108003/99108003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 19683 | CHIESI ESPAÑA S.A.U. | 2010-04-15 | 1 | 1 | 1 | 2010-04-15 | 2010-04-15 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 665232 | 97045001 | HELICOBACTER TEST INFAI 75 mg POLVO PARA SOLUCION ORAL | HELICOBACTER TEST INFAI 75 mg POLVO PARA SOLUCION ORAL, 1 frasco de 10 ml | 75 mg | 6 | 1 | 34 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97045001/97045001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97045001/97045001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41376 | INFAI GMBH | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 0 | 2021-10-18 | View Edit Delete | ||||||||||||
| 664459 | 71779 | RIVASTIGMINA VIR 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA VIR 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71779/71779_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71779/71779_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2012-10-18 | View Edit Delete | ||||||||||||
| 664461 | 71781 | RIVASTIGMINA ORTODROL 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA ORTODROL 2 mg/ml SOLUCION ORAL EFG, 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71781/71781_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71781/71781_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2011-04-14 | View Edit Delete | ||||||||||||
| 665364 | 61617 | ADOLONTA 100 mg/ ml SOLUCION ORAL | ADOLONTA 100 mg/ ml SOLUCION ORAL , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61617/61617_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61617/61617_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 665041 | 71180 | AZITROMICINA SANDOZ 200 MG/5 ML POLVO PARA SUSPENSIÓN ORAL EFG | AZITROMICINA SANDOZ 200 MG/5 ML POLVO PARA SUSPENSIÓN ORAL EFG , 1 frasco de 15 ml | 200 mg/5 ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71180/71180_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71180/71180_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-04-20 | 1 | 1 | 1 | 2010-04-20 | 2010-04-20 | 1 | 2011-11-23 | View Edit Delete | ||||||||||||
| 665142 | 71180 | AZITROMICINA SANDOZ 200 MG/5 ML POLVO PARA SUSPENSIÓN ORAL EFG | AZITROMICINA SANDOZ 200 MG/5 ML POLVO PARA SUSPENSIÓN ORAL EFG , 1 frasco de 30 ml | 200 mg/5 ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71180/71180_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71180/71180_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-04-20 | 1 | 1 | 1 | 2010-04-20 | 2010-04-20 | 1 | 2013-01-29 | View Edit Delete | ||||||||||||
| 664929 | 72005 | SEHCAT 370 KBQ CAPSULAS | SEHCAT 370 KBQ CAPSULAS, 1 cápsula | 370 kBq | 6 | 1 | 43 | 1 cápsula | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72005/72005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72005/72005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2010-03-24 | 1 | 1 | 1 | 2010-03-24 | 2010-03-24 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 663771 | 09533002 | VEDROP 50 MG/ML EN SOLUCION ORAL | VEDROP 50 MG/ML EN SOLUCION ORAL, 1 frasco de 20 ml | 50 mg/ml | 6 | 20 | 26 | 1 frasco de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/09533002/09533002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09533002/09533002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 663772 | 09533003 | VEDROP 50 MG/ML EN SOLUCION ORAL | VEDROP 50 MG/ML EN SOLUCION ORAL, 1 frasco de 60 ml | 50 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/09533003/09533003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09533003/09533003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2011-11-18 | View Edit Delete | ||||||||||||
| 664868 | 71913 | RIVASTIGMINA NORMON 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA NORMON 2 mg/ml SOLUCION ORAL EFG, 1 frasco de 120 ml | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71913/71913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71913/71913_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-02-24 | 1 | 1 | 1 | 2010-02-24 | 2010-02-24 | 1 | 2012-08-01 | View Edit Delete | ||||||||||||
| 663871 | 00146031 | KEPPRA 100 mg/ml SOLUCION ORAL | KEPPRA 100 mg/ml SOLUCION ORAL, 1 frasco de 150 ml con jeringa oral de 5 ml | 100 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml con jeringa oral de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00146031/00146031_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00146031/00146031_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 663873 | 00146032 | KEPPRA 100 mg/ml SOLUCION ORAL | KEPPRA 100 mg/ml SOLUCION ORAL, 1 frasco de 150 ml con jeringa oral de 1 ml | 100 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml con jeringa oral de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00146032/00146032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00146032/00146032_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2012-01-09 | View Edit Delete |
Page 217 of 1036, showing 20 records out of 20704 total, starting on record 4321, ending on 4340